CRISPR enables warfighter enhancement
Marsha Greene & Zubin Master, 2018, Senior Policy Analyst, Peraton & Biomedical Ethics Research Program, Mayo Clinic, https://www.ndu.edu/Portals/59/Documents/Incoming/AY21%20Briefings/NDU%206070/CRISPR_Military.pdf?ver=2020-08-11-170728-347, " Ethical Issues of Using CRISPR Technologies for Research on Military Enhancement" Journal of Bioethical Inquiry (ermo/sms, Acc:6-8-2022)
The development of the CRISPR/Cas 9 system has revived the debate over gene editing applications in many areas including biological research, human health, and agriculture and food production among others. What is discussed less in the literature is the use of CRISPR/Cas and other gene editing technologies to enhance humans specifically for military purposes. The President’s Council on Bioethics under former President George W. Bush acknowledged that when performance is a matter of life and death, such as with soldiers on the battlefield, human enhancement may be more acceptable and indeed allowable (President’s Council for Bioethics 2003). Yet the Council cautioned that it may be unwise to allow the warfighter to become indistinguishable from his weapon. Nevertheless, as evidenced by the Defense Advanced Research Projects Agency (DARPA) Broad Agency Announcement (BAA) in 2014, human performance optimization continues to be a major area of research focus (DARPABAA-14-38). In this call, DARPA solicited proposals to improve warfighter performance, improve bioengineering safety, and create a biological based manufacturing platform. The announcement underscores the Department’s current focus on temporary optimization measures to include the development of short acting drugs and biologics designed to enhance everything from wound healing to improvement of a broad range of cognitive abilities. With the emergence of CRISPR/Cas technology and the possibility for permanent gene enhancements of service members, the debate over where the ethical line should be drawn in military human performance optimization requires further consideration.
In this paper, we focus on the ethics of research using CRISPR on adult military service members, specifically as it relates to potential exposure to biological agents. This focus is deliberate because warfare is increasingly becoming asymmetrical with the emergence of guerrilla and insurgent forces. Military operations have shifted to counterinsurgency with specific attention regarding how to combat the threat of non-lethal weapons (e.g., bioagents). We discuss the governance of research involving humans in the military and follow with a discussion of how CRISPR can be used to protect warfighters against biological agents. Finally, we perform an ethical analysis of research involving military personnel specifically on issues of risks–benefit analysis, informed consent, and equality of access and outline several considerations for institutional review boards (IRBs) and policymakers.